Translucence and Zeiss Team Up to Expand Possibilities for 3D Tissue Imaging

Translucence Biosystems

March 24, 2021

We are excited to announce that Translucence Biosystems has entered into a collaborative and strategic relationship with Carl Zeiss AG to promote the use of the Mesoscale Imaging System^TMwith the new ZEISS Lightsheet 7 microscope, designed to advance the 3D histology revolution.

Learn more about the Zeiss Lightsheet microscopes here.

‍

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!

Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

January 31, 2023

Updates

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."

Translucence Biosystems

Learn More

November 13, 2022

Research

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.

Translucence Biosystems

Learn More

May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.

Angela Prvulovic

Learn More